The data we showed of inactivated influenza and bacterial polysaccharide vaccines adjuvanted with our Matrix-M are just ...

Another company developing a vaccine for herpes zoster is US biotech Curevo Vaccine, whose adjuvanted subunit vaccine CRV-101 is in early-stage clinical development. Discover how AI is ...

Q3 2024 Earnings Call Transcript November 7, 2024 Dynavax Technologies Corporation beats earnings expectations. Reported EPS ...

Dynavax Technologies (NASDAQ: DVAX) Q3 2024 Earnings Call Nov 07, 2024, 4:30 p.m. ET ...

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global leader in the discovery, development, manufacturing, and delivery of next-generation vaccines and ...

Genital Chlamydia trachomatis infection is a significant public health burden; Professor of Pediatrics and Microbiology and ...

Nova Scotia's Progressive Conservatives promised on Tuesday to introduce a universal shingles vaccine program for people 65 and older if re-elected Nov. 26, the latest in a series of targeted ...

The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zoster vaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Nov 6 (Reuters) - An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current mpox surge, the WHO and other health organisations said ...